Effectively Treating Community-Associated MRSA Infections
MRSA-related cases have been steadily making headlines across the country—pushing it into mainstream dialogue. What do you need to know as an alternate-site infusion professional? Find out from an authority on MRSA—Dr. Seth David Rosenbaum!
Program Description:
Methicillin-resistant Staph Aureus (MRSA) has emerged in the community with clinical, epidemiologic and bacteriologic characteristics distinct from healthcare associated MRSA. Community-Associated MRSA (CA-MRSA) infections are fast becoming common in the general population, requiring a change in therapeutic approach. Gather with colleagues to acquire the vital information essential for clinicians to have when making appropriate recommendations for the most effective therapy.
Dr. Rosenbaum was an expert speaker on this topic to over 200+ breakfast symposium attendees during the 2008 NHIA Annual Conference. Ideal for all alternate-site infusion clinicians, Dr. Rosenbaum will share his coveted knowledge through this highly-anticipated audio conference.
Faculty:
Seth David Rosenbaum, MD Medical Specialty Associates, Infectious Diseases, Cherry Hill, NJ
Faculty Bio:
Dr. Rosenbaum is currently an attending physician for infectious diseases and internal medicine at Medical Specialty Associates, PA. Throughout his career, Dr. Rosenbaum has provided emergency medical service to a New Jersey township, acted as an officer on a volunteer EMS rescue squad, and assisted with the evaluation and instruction of senior medical students in OSCE program.
Dr. Rosenbaum has received many awards in his field and holds certifications from the American Board of Internal Medicine and the American Board of Internal Medicine—Infectious Diseases among many others.
Educational Objectives:
After completion of this program the learner will:
- Discuss the emergence of Community Associated Methicillin resistant Staph Aureus (CA-MRSA).
- Outline the factors leading to increasing rates of S. Aureus bacteremia.
- List five risk factors for CA-MRSA.
- Identify specific benefits of early appropriate therapy when treating CA-MRSA.
- List the current FDA approved agents for treating CA MRSA.
Target Audience:
Clinical and other professionals in the alternate-site infusion community.
What is an MP3? "MP3" refers to files of sound or music recordings stored in the MP3 format on computers. This file type has become the standard file format for the compression of audio because MP3s significantly compress songs and files, making them the perfect candidate for distribution via downloads. Files can be accessed on your computer with applications such as Windows Media Player or Apple iTunes or can be played on MP3 players. More questions about this file format? Contact the NHIA office at 703-549-3740.
MP3s are sent via email — a valid email address is required on all MP3 orders.
